Choroidal Morphology Changes After Aflibercept Therapy in Pachychoroid Neovasculopathy

NCT05662410 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pachychoroid Neovasculopathy

Interventions

DRUG: Three monthly injections of intravitreal aflibercept

Sponsor

Kim's Eye Hospital

Collaborators

[object Object]
[object Object]